China (Mainland)
Galanthamine CAS NO.357-70-0
- Min.Order: 1 Metric Ton
- Payment Terms: L/C,D/A,D/P,T/T,
- Product Details
Keywords
- Galanthamine
- 357-70-0
- 3,4-Dihydrogalanthamine
Quick Details
- ProName: Galanthamine
- CasNo: 357-70-0
- Molecular Formula: C17H21NO3
- Appearance: White Powder
- Application: Pharmaceutical intermediates
- DeliveryTime: With three or five working days
- PackAge: 25kg/fiber drum, sealed package
- Port: China main port
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.48%
- Storage: Seald package, keep away from light
- Transportation: Sealed package, keep away from light
- LimitNum: 1 Metric Ton
- Valid Period: 2020-12-18
Superiority
1. Advanced facility and Equipment
2. Competent technical team
3 .Strong R & D support
4,high quality products with high stability
5, Competitive price
5.Customer tailored service
Details
|
Product Name |
Galanthamine base |
|
Another Name |
Galanthamine |
|
Specification |
98% |
|
Appearance |
White Powder |
| CAS.NO |
357-70-0 |
| Molecular Formula |
C17H22ClNO3 |
|
Test Method |
HPLC |
|
Extract Method |
Ethanol |
|
Grade |
Pharmaceutical grade |
|
Brand Name |
HLT |
|
Package |
Aluminum foil bag / Drum |
|
Storage |
Store in cool and dry places. Keep away from strong sunlight |
|
Physical: |
|
|
Loss on Drying |
≤5.0% |
|
Bulk density |
40-60g/100ml |
|
Sulphated Ash |
≤5.0% |
|
GMO |
Free |
|
General Status |
Non-irradiated |
|
Heavy Metal: |
|
|
Pb |
≤0.2ppm |
|
As |
≤0.3ppm |
|
Hg |
≤0.3ppm |
|
Cd |
≤0.1ppm |
|
Microbial: |
|
|
Total microbacterial count |
≤1000cfu/g |
|
Yeast & Mold |
≤100cfu/g |
|
E.Coli |
Negative |
|
Staphylococcus aureus |
Negative |
|
Salmonella |
Negative |
|
Enterobacteriaceaes |
Negative |
1 This product is the anti-cholinesterase, weak effect. I t has strong effect to the central nervous system through the blood brain barrier. It mainly cures the infantile paralysis sequelae, sweeny and myasthenia gravis pseudoparalytica, etc. It also can be applied to puerilism, posttraumatic apoplexy, polyneuritis and radiculitis.
2 Clinic function: mainly used in myasthenia gravis, poliovirus quiescent stage and sequela, also in polyneuritis, funiculitis and sensorimotor barrier caused by nervous system disease or traumatism. It’s major used in Alzheimer's disease, has the principal function for dement and dysmnesia caused by organic brain damage.
